PCSK9 inhibitor valuation: A science‐based review of the two recent models

Low‐density lipoprotein cholesterol (LDL‐C) has been extensively evaluated. Prospective cohort studies, randomized controlled trials, biology, pathophysiology, genetics, and Mendelian randomization studies, have clearly taught us that LDL‐C causes atherosclerotic cardiovascular disease. The newest c...

Descripción completa

Detalles Bibliográficos
Autores principales: Baum, Seth J., Cannon, Christopher P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2018
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947644/
https://www.ncbi.nlm.nih.gov/pubmed/29512936
http://dx.doi.org/10.1002/clc.22924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947644/
https://www.ncbi.nlm.nih.gov/pubmed/29512936
http://dx.doi.org/10.1002/clc.22924

Ejemplares similares